We are live on ! Find out more
ADAG

Adagene

11 hedge funds and large institutions have $15.5M invested in Adagene in 2023 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

152% more capital invested

Capital invested by funds: $6.16M → $15.5M (+$9.35M)

100% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 1

10% more funds holding

Funds holding: 10 → 11 (+1)

6.91% more ownership

Funds ownership: 9.35% → 16.25% (+6.9%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

Holders
11
Holders Change
+1
Holders Change %
+10%
% of All Funds
0.16%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
2
Increased
1
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$62.6K
2
UBS Group
UBS Group
Switzerland
+$2

ADAG Hedge Fund Activity: Q4 2023 in Review

11 of the 6,871 institutional investors tracked by Wall St. Rank reported a position in Adagene (ADAG) for Q4 2023, worth a combined $15.5M — up 152% from $6.16M a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new ADAG positions and 1 closed out — a net gain of 1 holder — while 1 added to existing stakes and 1 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $62.6K. The largest seller was Fidelity Investments, cutting an estimated $1.51M.

  • 11 institutional investors held Adagene (ADAG) as of Q4 2023, up from 10 in Q3 2023.
  • Funds reported $15.5M of Adagene stock for Q4 2023, up 152% quarter-over-quarter.
  • 2 funds opened new Adagene positions in Q4 2023 and 1 closed out, a net change of +1 holder.
  • The largest Adagene buyer in Q4 2023 was Morgan Stanley, an estimated $62.6K added.
  • The largest Adagene seller in Q4 2023 was Fidelity Investments, an estimated $1.51M sold.

Based on aggregated 13F filings for Q4 2023.